Big Leap Health is dedicated to transforming access to mental healthcare by empowering clinics to launch and scale interventional psychiatry practices. Specializing in innovative treatments such as Spravato (esketamine) and Transcranial Magnetic Stimulation (TMS), the company aims to establish a new standard of care through comprehensive operational, administrative, and clinical support. Founded by leaders in mental health and healthcare technology, Big Leap Health is backed by top-tier investors and is committed to improving patient outcomes with cutting-edge therapies. The company invites individuals to join in pioneering the future of mental health.